A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population

Inclusion Criteria

• •Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
• •Male or female, age above or equal to 18 years at the time of signing informed consent.
• •Licensed to practice medicine in one of the countries of interest: United States, Canada, France, Germany, Japan
• •Must be a practicing endocrinologist, hepatologist, cardiologist, obesity specialist, primary care physician, radiologist, nurse practitioner or physician assistant (NP/PA US only)
• •Must be at least "somewhat familiar" (as opposed to "not at all familiar) with Metabolic dysfunction-associated steatohepatitis (MASH) (do not need to be currently treating people with MASH) 6. Must have at least 2 years in practice 7. Must spend at least 50 percentage of their time in patient care
• •Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
• •Male or female, age above or equal to 18 years at the time of signing informed consent.
• •Diagnosis of MASH or Metabolic Associated Steatotic Liver Disease (MASLD) within past 24 months
• •Live in one of the countries of interest: United States, Canada, France, Germany, Japan
• •Have at least one comorbid condition: obesity, pre-diabetes, type 2 diabetes (T2D), metabolic syndrome, dyslipidaemia, hypertension, cardiovascular disease, chronic kidney disease
• •Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
• •Male or female, age above or equal to 18 years at the time of signing informed consent.
• •Live in one of the countries of interest: United States, Canada, France, Germany, Japan
• •Must have one or more risk factors associated with MASH \[obesity, pre-diabetes, type 2 diabetes (T2D), metabolic syndrome, dyslipidaemia, hypertension, cardiovascular disease, chronic kidney disease\], be diagnosed with steatosis (incidental finding) or have a blood test that shows raised liver enzymes.